UNSPSC 51182037: Norclostebol

This classification denotes an anabolic steroid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VI1001O2DI. European Medicines Agency schedules Norclostebol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09356MIG. Norclostebol generally arises in the molecular formula C18H25CLO2. The term NORCLOSTEBOL is an International Non-Proprietary Name or INN. NORCLOSTEBOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule norclostebol under HS 29372900 and SITC 54153. As of Q4 2014, NORCLOSTEBOL remains the US FDA Preferred Term for this commodity. Norclostebol bears US NLM identifiers UMLS ID C2698495 and NCI Concept Code C77307. SMILES: CLC1=C2C(C3C(C4C(CC3)(C(O)CC4)C)CC2)CCC1=O.

I cannot produce a summary of UNSPSC 51182037 Norclostebol as a Commodity code. The source provides no information about state and local procurement activity, recent opportunities, issuing bodies, or geographic distribution under this code. Norclostebol is a controlled anabolic steroid; state and local governments do not appear in the public procurement record as buyers of this substance. Without evidence of actual state or local solicitation activity, characterizing procurement patterns or issuing-body mix would require speculation unsupported by source material.